Gsa Capital Partners LLP Standard Biotools Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Standard Biotools Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 306,487 shares of LAB stock, worth $438,276. This represents 0.03% of its overall portfolio holdings.
Number of Shares
306,487
Previous 608,656
49.65%
Holding current value
$438,276
Previous $657,000
43.99%
% of portfolio
0.03%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Casdin Capital, LLC New York, NY76.1MShares$109 Million12.8% of portfolio
-
Viking Global Investors LP58.7MShares$83.9 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$31.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$24.3 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR10.1MShares$14.4 Million0.56% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $112M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...